JP2025515358A5 - - Google Patents
Info
- Publication number
- JP2025515358A5 JP2025515358A5 JP2024563636A JP2024563636A JP2025515358A5 JP 2025515358 A5 JP2025515358 A5 JP 2025515358A5 JP 2024563636 A JP2024563636 A JP 2024563636A JP 2024563636 A JP2024563636 A JP 2024563636A JP 2025515358 A5 JP2025515358 A5 JP 2025515358A5
- Authority
- JP
- Japan
- Prior art keywords
- nutritionally
- pharmaceutically
- solvate
- acceptable salt
- therapeutically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22382390 | 2022-04-25 | ||
| EP22382390.7 | 2022-04-25 | ||
| PCT/EP2023/060827 WO2023208944A1 (en) | 2022-04-25 | 2023-04-25 | Pharmaceutical and nutraceutical compositions with a combination of amino acids and its use in diseases characterized by lipid accumulation in tissues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515358A JP2025515358A (ja) | 2025-05-14 |
| JP2025515358A5 true JP2025515358A5 (cg-RX-API-DMAC7.html) | 2026-05-08 |
Family
ID=81579974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563636A Pending JP2025515358A (ja) | 2022-04-25 | 2023-04-25 | アミノ酸の組合せを有する医薬組成物および栄養補助組成物ならびに組織への脂質蓄積を特徴とする疾患におけるその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250268855A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4514147A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025515358A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119343061A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3249636A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024013203A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023208944A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190146A1 (ar) * | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| US11246846B2 (en) * | 2017-10-23 | 2022-02-15 | Michael S. Tempesta | Trisodium citrate compositions having enhanced uptake across digestive mucosa |
-
2023
- 2023-04-25 US US18/859,892 patent/US20250268855A1/en active Pending
- 2023-04-25 CA CA3249636A patent/CA3249636A1/en active Pending
- 2023-04-25 WO PCT/EP2023/060827 patent/WO2023208944A1/en not_active Ceased
- 2023-04-25 EP EP23722509.9A patent/EP4514147A1/en active Pending
- 2023-04-25 JP JP2024563636A patent/JP2025515358A/ja active Pending
- 2023-04-25 CN CN202380049301.0A patent/CN119343061A/zh active Pending
-
2024
- 2024-10-25 MX MX2024013203A patent/MX2024013203A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5866537A (en) | Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids | |
| CN110087647B (zh) | 氨基酸组合物及肝疾病的治疗方法 | |
| JP5672264B2 (ja) | 抗ヒトTNF−α抗体活性低下抑制剤 | |
| JP2020504108A5 (cg-RX-API-DMAC7.html) | ||
| ES2759584T3 (es) | Prevención y tratamiento de afecciones inflamatorias | |
| Wang et al. | Anti-inflammatory activity of di-peptides derived from ovotransferrin by simulated peptide-cut in TNF-α-induced Caco-2 cells | |
| CN104434894A (zh) | 使用l-鸟氨酸苯乙酸盐治疗门静脉高压和恢复肝功能 | |
| TW200539860A (en) | HMB compositions and uses thereof | |
| CA2631647A1 (en) | Use of branched-chain amino acids for the treatment of muscle loss | |
| US20110077198A1 (en) | Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition | |
| US7094797B2 (en) | Organ fibrosis inhibitor | |
| US20170290788A1 (en) | Pharmaceutical for oral delivery comprising mgbg and methods of treating disease | |
| JP2021529736A (ja) | 炎症の軽減又は治療のための組成物及び方法 | |
| CN112689508A (zh) | 减少或治疗胰岛素抗性和代谢病状的组合物和方法 | |
| JP2021517578A (ja) | カルシウム欠乏に起因する状態の治療に使用するための組成物 | |
| CN102458417B (zh) | 核酸类似物的活性增强剂 | |
| JP2025519127A5 (cg-RX-API-DMAC7.html) | ||
| JP2021527669A5 (cg-RX-API-DMAC7.html) | ||
| JP6119969B2 (ja) | 血圧降下用アミノ酸含有組成物 | |
| US20210127647A1 (en) | Non-Human Animal Model of Non-Alcoholic Fatty Liver Disease | |
| CN101014334B (zh) | 丙型肝炎病毒阳性人肝硬化患者用肝癌发生和发展抑制剂 | |
| CN1287855C (zh) | B型慢性肝炎治疗剂 | |
| JP2021066662A (ja) | 肝脂肪低減剤 | |
| CN101060854A (zh) | 具有抗糖尿病作用的蛋白质水解物 | |
| JP5100033B2 (ja) | 消化管及び腎臓の萎縮抑制剤 |